SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) and (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)*
VeriSign, Inc. |
||||
| (Name of Issuer) | ||||
Common Stock, $0.01 par value |
||||
| (Title of Class of Securities) | ||||
92343E10-2 |
||||
(CUSIP Number) |
||||
May 21, 2001 |
||||
| (Date of Event Which Requires Filing of this Statement) | ||||
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
/ / Rule 13d-1(b)
/x/ Rule 13d-1(c)
/ / Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 92343E10-2 | 13G | Page 1 of 4 Pages |
| (1) | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). |
|||||
Science Applications International Corporation SAIC Venture Capital Corporation |
95-3630868 88-0447177 |
|||||
| (2) | Check the Appropriate Box if a Member | (a) | / / | |||
| of a Group (See Instructions) | (b) | / / | ||||
| (3) | Sec Use Only | |||||
| (4) | Citizenship or Place of Organization | |||||
Science Applications International Corporation SAIC Venture Capital Corporation |
Delaware Nevada |
|||||
| Number of Shares Beneficially Owned by Each Reporting Person With: | (5) | Sole Voting Power | ||||
None |
||||||
| (6) | Shared Voting Power | |||||
12,277,500 |
||||||
| (7) | Sole Dispositive Power | |||||
None |
||||||
| (8) | Shared Dispositive Power | |||||
12,277,500 |
||||||
| (9) | Aggregate Amount Beneficially Owned by Each Reporting Person | |||||
12,277,500 |
||||||
| (10) | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) / / | |||||
| (11) | Percent of Class Represented by Amount in Row (9) | |||||
6% |
||||||
| (12) | Type of Reporting Person (See Instructions) | |||||
Science Applications International Corporation SAIC Venture Capital Corporation |
CO CO |
|||||
| CUSIP No. 92343E10-2 | 13G | Page 2 of 4 Pages |
Item 1(a). Name of Issuer:
VeriSign, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
1350
Charleston Rd.
Mountain View, California 94043
Item 2(a). Name of Person Filing:
Science
Applications International Corporation
SAIC Venture Capital Corporation
Item 2(b). Address of Principal Business Office or, if None, Residence:
Science
Applications International Corporation
10260 Campus Point Drive
San Diego, California 92121
SAIC
Venture Capital Corporation
3993 Howard Hughes Parkway
Suite 570
Las Vegas, Nevada 89109
Item 2(c). Citizenship:
Science Applications International Corporation Delaware
SAIC Venture Capital Corporation Nevada
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
92343E10-2
| CUSIP No. 92343E10-2 | 13G | Page 3 of 4 Pages |
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
| (a) | / / | Broker or dealer registered under Section 15 of the Act; | ||
(b) |
/ / |
Bank as defined in Section 3(a)(6) of the Act; |
||
(c) |
/ / |
Insurance company as defined in Section 3(a)(19) of the Act; |
||
(d) |
/ / |
Investment company registered under Section 8 of the Investment Company Act of 1940; |
||
(e) |
/ / |
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); |
||
(f) |
/ / |
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); |
||
(g) |
/ / |
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); |
||
(h) |
/ / |
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; |
||
(i) |
/ / |
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940; |
||
(j) |
/ / |
Group, in accordance with Rule 13d-1(b)(1)(ii)(J). |
Item 4. Ownership.
Item 4 is hereby being amended and restated as follows:
Item 5. Ownership of Five Percent or Less of a Class.
N/A
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
N/A
| CUSIP No. 92343E10-2 | 13G | Page 4 of 4 Pages |
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
N/A
Item 8. Identification and Classification of Member of the Group.
N/A
Item 9. Notice of Dissolution of Group.
N/A
Item 10. Certifications.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 12, 2002
| SCIENCE APPLICATIONS INTERNATIONAL CORPORATION | |||
By: |
/s/ DOUGLAS E. SCOTT Name: Douglas E. Scott Title: Senior Vice President and General Counsel |
||
SAIC VENTURE CAPITAL CORPORATION |
|||
By: |
/s/ KEVIN A. WERNER Name: Kevin A. Werner Title: President |
||
EXHIBIT A
AGREEMENT AS TO JOINT FILING OF SCHEDULE 13G
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing, on behalf of each of them, of a Statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of VeriSign, Inc. Each of the undersigned states that it is entitled to individually use Schedule 13G pursuant to Rule 13d-1(c) of the Act. Each of the undersigned is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
Date: February 12, 2002
| SCIENCE APPLICATIONS INTERNATIONAL CORPORATION | |||
By: |
/s/ DOUGLAS E. SCOTT Name: Douglas E. Scott Title: Senior Vice President and General Counsel |
||
SAIC VENTURE CAPITAL CORPORATION |
|||
By: |
/s/ KEVIN A. WERNER Name: Kevin A. Werner Title: President |
||